Catalyst Wire Dossier Catalyst Wire Dossier

BBIBP-CcorV

BBIBP-CorV · China National Biotec Group Company Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBIBP-CcorV, covering 2021-11-02 to 2021-11-02. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD [Phase 4]

See pricing